OPN3 and cutaneous melanoma: In the external dataset of cutaneous melanoma (GSE98394), we observed a significant difference in the level of OPN3 gene expression that affected patient overall survival between the upper 50% group versus other 50% group (p = .014) (Figure S2), which suggested that the upregulation of the OPN3 expression is associated with poor disease outcome of cutaneous melanoma.